Report Overview: The Global 3D Bioprinting Market achieved a valuation of $1.20 Billion in 2022 and is anticipated to exceed $5.19 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 20.1% during the forecast period from 2024 to 2032. Key Market Players: Envisiontec Inc., Organovo Holdings Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio LLC, Allevi,...